Normal antibody response after COVID-19 during treatment with cladribine
Elisabeth Gulowsen Celius
Topics & Concepts
CladribineMedicineMultiple sclerosisCoronavirus disease 2019 (COVID-19)ImmunologyAntibody2019-20 coronavirus outbreakImmune systemSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyInternal medicineDiseaseInfectious disease (medical specialty)OutbreakMultiple Sclerosis Research StudiesChronic Lymphocytic Leukemia ResearchPolyomavirus and related diseases